Vanberra Signal

Laverock Therapeutics

Curated by Signal

Developer of next generation of programmable cell therapies

Overview

Developer of next generation of programmable cell therapies. The company utilizes gene editing induced gene silencing (GEiGS) technology, and its associated computational platform, to engineer induced pluripotent stem cell (iPSC) derived cell therapies.

Key facts

Founded
2021

Business model

Contact

More on Vanberra Signal

Members only

Competitors & similar companies

More Health Technology companies
  • Provider of platform for fitness professionals for content creation

    Health TechnologyLondon, United Kingdom
  • Mobile application offering wellness services for women

    Health TechnologyLondon, United Kingdom
  • Provider of platform for online psychological therapies

    Health TechnologyLondon, United Kingdom

About Laverock Therapeutics

What does Laverock Therapeutics do?

Developer of next generation of programmable cell therapies.

Where is Laverock Therapeutics headquartered?

Laverock Therapeutics is headquartered in Stevenage, United Kingdom.

When was Laverock Therapeutics founded?

Laverock Therapeutics was founded in 2021.

Which sector is Laverock Therapeutics in?

Laverock Therapeutics operates in Health Technology.

Who are Laverock Therapeutics's competitors?

Companies similar to Laverock Therapeutics include bodiclub, Curate, and ICS Digital Therapies.